Stay updated on Pembro & HER2Bi-ACT for Met CRPC Clinical Trial

Sign up to get notified when there's something new on the Pembro & HER2Bi-ACT for Met CRPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembro & HER2Bi-ACT for Met CRPC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now displays the full ClinicalTrials.gov record for the completed phase II prostate cancer study, including its treatment plan, eligibility criteria, outcomes, investigators, and record dates, instead of a 403 error page.
    Difference
    48%
    Check dated 2026-11-11T01:14:32.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0; the page still shows a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-11-03T23:29:20.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    A site-wide NIH notice about the website transition and terminology was added, and the site revision advanced from v3.7.1 to v3.7.2. The study page itself remains a 403 Forbidden error.
    Difference
    1%
    Check dated 2026-10-20T23:07:34.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The footer’s site revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:28:16.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, indicating access to the study record is blocked. The previous study content and documents are no longer visible, replaced by the error message.
    Difference
    18%
    Check dated 2026-09-23T00:40:28.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.6 to v3.7.0, indicating a software version update for the page. No visible changes to study details are indicated.
    Difference
    0.1%
    Check dated 2026-09-15T23:37:22.000Z thumbnail image

Stay in the know with updates to Pembro & HER2Bi-ACT for Met CRPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembro & HER2Bi-ACT for Met CRPC Clinical Trial page.